No Picture
Trading Ideas

Tesla Pares Advance After Einhorn Questions Billings Again

(Bloomberg) — David Einhorn, the president of hedge fund Greenlight Capital, questioned Tesla Inc.’s billing practices again in his latest repartee with the electric-car maker’s chief executive officer, Elon Musk.“I guess the offer of a factory tour was never serious,” Einhorn said in a tweet, referring to an invitation Musk extended last year for the long-time Tesla short seller to visit the company’s plants.Einhorn, who five months ago told Musk he was “beginning to wonder whether your accounts receivable exist,” said Tesla has in the past explained that the balance of money owed by its debtors was elevated by sales …read more […]

No Picture
Trading Ideas

Is Gilead Sciences Stock a Buy Right Now? This Is What You Need to Know

COVID-19 killed the bull market in stocks this year, but at least one stock hasn’t been fazed by the virus. To the contrary, Gilead Sciences (GILD), maker of the Ebola drug-turned-coronavirus drug remdesivir, is enjoying its own private bull market, with its shares up 27% since the year began.On Wednesday, Gilead shared some of its good fortune with the rest of the stock market, too, as a pair of new remdesivir data releases helped spark a rally that sent the S&P 500 up 2.7%.So what did Gilead have to say today?Firstly, according to the company, a National Institute of Allergy …read more […]